• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 22, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Cannibal cells may limit cancer growth

Bioengineer by Bioengineer
July 11, 2017
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Credit: Dr Jo Durgan, Babraham Institute

Cell cannibalism in tumour samples has been observed for over a century, yet this unusual behaviour is not well studied. New research led by scientists at the Babraham Institute, Cambridge reveals a new mechanism driving cell cannibalism that offers surprising insights into cancer biology.

Cell cannibalism, also called entosis, occurs when one cell surrounds, kills and digests another. Entosis doesn't typically happen between healthy cells but it is common in tumours. This latest research, published in the journal eLife, reveals that cannibalism can be triggered by cell division; when one cell divides to form two. Since uncontrolled cell division is a key hallmark of cancer, this suggests that cannibalism may have a role to play in resisting cancer.

The research, which also includes scientists from Memorial Sloan Kettering Cancer Centre, USA and the Francis Crick Institute in London, examined human epithelial cells. These cells form many of the surfaces in the body and give rise to over 80% of human cancers. Normally, epithelial cells remain firmly attached to their surroundings when they divide. This study shows that weakened attachments result in more cell cannibalism. This may explain why drugs that weaken cell attachments are effective anti-cancer drugs.

First author on the paper, Dr Jo Durgan, said: "We set out to identify the proteins that control cell cannibalism in tumour cells, but by using time-lapse microscopy to watch this process in action, we stumbled across a completely unexpected new mechanism. The link we've found to cell division is really intriguing from the perspective of cancer."

Cell cannibalism has a complex relationship with cancer and it is not totally clear whether it helps or hinders tumour growth. However, the discovery that dividing cells are more likely to be cannibalised by other cells suggests that entosis may help to slow or prevent cancer by causing cancer cells to be consumed and destroyed by nearby healthy cells.

Lead scientist on the paper, Dr Oliver Florey, said: "Entosis is a fascinating process that may play a role in normal physiology, as well as cancer. By studying entosis, we hope to gain insights into fundamental cell biology, as well as to explore intriguing new avenues for cancer research. After 100 years of observing 'cell-in-cell' structures, there is now an exciting push towards discoveries in both cell and cancer biology."

###

Media Contact

Jonathan Lawson
[email protected]
01-223-496-230
@babrahaminst

http://www.babraham.ac.uk/

Original Source

http://www.babraham.ac.uk/news/2017/07/cannibal-cells-may-limit-cancer-growth http://dx.doi.org/10.7554/eLife.27134

Share12Tweet8Share2ShareShareShare2

Related Posts

Tirzepatide Versus GLP-1 Agonists for Stroke Risk in Atrial Fibrillation and Diabetes

August 22, 2026
Real-world study examines psychotic complications of subcutaneous foslevodopa/foscarbidopa infusions in 198 patients

Real-world study examines psychotic complications of subcutaneous foslevodopa/foscarbidopa infusions in 198 patients

August 22, 2026

Blood-flow signals from liver vessels direct region-specific liver function through Wnt pathways

August 22, 2026

Proteomics Links Environmental and Genetic Parkinson’s Models to Purine Metabolism

August 22, 2026
Please login to join discussion

POPULAR NEWS

  • Tirzepatide Versus GLP-1 Agonists for Stroke Risk in Atrial Fibrillation and Diabetes

    29 shares
    Share 12 Tweet 7
  • Real-world study examines psychotic complications of subcutaneous foslevodopa/foscarbidopa infusions in 198 patients

    29 shares
    Share 12 Tweet 7
  • Blood-flow signals from liver vessels direct region-specific liver function through Wnt pathways

    29 shares
    Share 12 Tweet 7
  • Ge/SiGe Quantum-Well Photodetectors Integrated with SiN Waveguides on 200-mm Silicon Wafers

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tirzepatide Versus GLP-1 Agonists for Stroke Risk in Atrial Fibrillation and Diabetes

Real-world study examines psychotic complications of subcutaneous foslevodopa/foscarbidopa infusions in 198 patients

Blood-flow signals from liver vessels direct region-specific liver function through Wnt pathways

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.